Evidence map›Paper›PMID 35662224›Full record

ArticleNeural regeneration research2022

Involvement of NLRP3-inflammasome pathway in noise-induced hearing loss.

Na Sai, Yuan-Yuan Yang, Long Ma, Da Liu, Qing-Qing Jiang, Wei-Wei Guo, Wei-Ju Han

Open access · goldAbstract read
In one paragraph

Article in Neural regeneration research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Therapeutic Potential of MgHNeuroscience bulletin · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Targeting NLRP3/caspase-1/GSDMD to treat inner ear injury from labyrinthine hemorrhage.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  12. Advances in the Study of NOD-Like Receptors in Common Otological Diseases.The journal of international advanced otology · 2025
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. A Selection Protocol to Identify Therapeutics to Target NLRP3-Associated Sensory Hearing Loss.Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Na SaiCollege of Otolaryngology Head and Neck Surgery, Chinese PLA General Hospital; National Clinical Research Center for Otolaryngologic Diseases; Key Laboratory of Hearing Science, Ministry of Education; Beijing Key Laboratory of Hearing Impairment for Prevention and Treatment, Beijing, China.
Yuan-Yuan YangDepartment of Otolaryngology Head and Neck Surgery, Peking University Shenzhen Hospital, Shenzhen, Guangdong Province, China.
Long MaPLA Rocket Force Characteristic Medical Center Department of Stomatology, China.
Da LiuCollege of Otolaryngology Head and Neck Surgery, Chinese PLA General Hospital; National Clinical Research Center for Otolaryngologic Diseases; Key Laboratory of Hearing Science, Ministry of Education; Beijing Key Laboratory of Hearing Impairment for Prevention and Treatment, Beijing, China.
Qing-Qing JiangCollege of Otolaryngology Head and Neck Surgery, Chinese PLA General Hospital; National Clinical Research Center for Otolaryngologic Diseases; Key Laboratory of Hearing Science, Ministry of Education; Beijing Key Laboratory of Hearing Impairment for Prevention and Treatment, Beijing, China.
Wei-Wei GuoCollege of Otolaryngology Head and Neck Surgery, Chinese PLA General Hospital; National Clinical Research Center for Otolaryngologic Diseases; Key Laboratory of Hearing Science, Ministry of Education; Beijing Key Laboratory of Hearing Impairment for Prevention and Treatment, Beijing, China.
Wei-Ju HanCollege of Otolaryngology Head and Neck Surgery, Chinese PLA General Hospital; National Clinical Research Center for Otolaryngologic Diseases; Key Laboratory of Hearing Science, Ministry of Education; Beijing Key Laboratory of Hearing Impairment for Prevention and Treatment, Beijing, China.
Chinese PLA General Hospital · CNMinistry of Education of the People's Republic of China · CNNational Clinical Research Center for Digestive Diseases · CNPeking University Shenzhen Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The inflammasome is a multiprotein oligomer in the cell cytoplasm and is part of the innate immune system. It plays a crucial role in the pathological process of noise-induced hearing loss (NIHL). However, the mechanisms of NLR family pyrin domain containing 3 (NLRP3) inflammasome activation in NIHL have not been clearly demonstrated. In this study, miniature pigs were exposed to white noise at 120 dB(A) and auditory brainstem response measurements were used to measure their hearing function. Immunofluorescence staining, confocal laser scanning microscopy, western blot assay, and quantitative reverse transcription-polymerase chain reaction were used to analyze inflammasome-related protein distribution and expression. NLRP3, interleukin-1β, interleukin-18, and cleaved-caspase-1 were highly expressed in the cochlea after 120 dB(A) white noise exposure. Our findings suggest that NLRP3-inflammasomes in the cochlea may be activated after acoustic trauma, which may be an important mechanism of noise-induced hearing loss.

Indexed as

acoustic injuryinflammasomeinterleukin-1βminiature pigNLR family pyrin domain containing 3 (NLRP3)noise-induced hearing losssensorineural hearing loss

Identifiers

PMID35662224
PMCPMC9165387
OpenAlexW4282941555

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.